FDA Inspection
Par PharmaceuticalsPar Pharmaceuticals – FDA Inspection, Feb 4, 2010
Record Details
This FDA Inspection record concerns Par Pharmaceuticals, with an inspection on February 4, 2010, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Par Pharmaceuticals
- Inspection Date
- February 4, 2010
- Product Type
- Drugs
View Company Profile
ID · 7283ada1-ddd2-462d-b028-b85e89e5d426
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 643932
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
2- 21 CFR 211.198(b)(2)Complaint Investigation/Follow-Up Findings
- 21 CFR 211.198(b)(3)Determination not to conduct investigation of complaint
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Par Pharmaceuticals
2| Date | Classification | Office | Project area |
|---|---|---|---|
| June 30, 2010 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 13, 2008 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Par Pharmaceuticals
- FDA Inspection 671887 - 2010-06-30
- FDA Inspection 554174 - 2008-11-13
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.